This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Founded | 2001 |
---|---|
Location | |
Key people | Justin Mendoza, Executive Director, UAEM North America Anna Peiris, Executive Director, UAEM Europe |
Website | www |
Universities Allied for Essential Medicines (UAEM) is a student-led organization working to improve access to and affordability of medicines around the world, and to increase research and development of drugs for neglected tropical diseases. Supported by an active board of directors and guided by an advisory board that includes Partners in Health co-founder Paul Farmer and Nobel Laureate Sir John Sulston, UAEM has mobilized hundreds of students on more than 100 campuses in more than 20 countries. [1] These student advocates have convinced universities worldwide to adopt equitable global access licensing policies for licensing their medical research, in order to make life-saving health innovations affordable and accessible in low and middle income countries. UAEM has published two student-led research projects—the University Report Card, which ranks universities on their contributions to global health and has received coverage in The New York Times [2] and others; and Re:Route, a mapping of biomedical research and development (R&D) alternatives. [3]
The organization has worked globally on a campaign aimed at encouraging the WHO to discuss an R&D agreement, and is now currently working on a campaign targeting agencies providing public funding for biomedical research around the world under the name Take Back Our Medicines (TBOM). [4]
The basic units of the organizations are called chapters. A chapter is a self-organised group of students, primarily based at an academic institution often with faculty support. Chapters range in size, from more intimate groups of 2 or 3, to larger gatherings of around 30 or more students. [5] UAEM chapters are present in the US, United Kingdom, Canada, Australia, Iran, India, Brazil, Sudan, Austria, Switzerland, Germany, Denmark and The Netherlands.
Universities Allied for Essential Medicines suggested that government should require necessary measures are in place for availability and affordability of COVID-19 related drugs, tests, or vaccines. [6]
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
UMass Chan Medical School is a public medical school in Worcester, Massachusetts. It is part of the University of Massachusetts system. It is home to three schools: the T.H. Chan School of Medicine, the Morningside Graduate School of Biomedical Sciences, and the Tan Chingfen Graduate School of Nursing, as well as a biomedical research enterprise and a range of public-service initiatives throughout the state.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
The Campaign for Access to Essential Medicines is an international campaign started by Médecins Sans Frontières (MSF) to increase the availability of essential medicines in developing countries. MSF often has difficulties treating patients because the medicines required are too expensive or are no longer produced. Sometimes, the only drugs available are highly toxic or ineffective, and they often have to resort to inadequate testing methods to diagnose patients.
James Packard Love is the director of Knowledge Ecology International, formerly known as the Consumer Project on Technology, a non-governmental organization with offices in Washington, D.C., and Geneva, that works mainly on matters concerning knowledge management and governance, including intellectual property policy and practice and innovation policy, particularly as they relate to health care and access to knowledge.
The Cuban government operates a national health system and assumes fiscal and administrative responsibility for the health care of all its citizens. All healthcare in Cuba is free to Cuban residents, although challenges include low salaries for doctors, poor facilities, poor provision of equipment, and the frequent absence of essential drugs. There are no private hospitals or clinics as all health services are government-run. The current public health minister of Cuba is José Angel Portal Miranda.
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all the member nations of the World Trade Organization (WTO). It establishes minimum standards for the regulation by national governments of different forms of intellectual property (IP) as applied to nationals of other WTO member nations. TRIPS was negotiated at the end of the Uruguay Round of the General Agreement on Tariffs and Trade (GATT) between 1989 and 1990 and is administered by the WTO.
Jonas Edward Salk was an American virologist and medical researcher who developed one of the first successful polio vaccines. He was born in New York City and attended the City College of New York and New York University School of Medicine.
The Health Impact Fund is a proposed pay-for-performance mechanism that would provide a market-based solution to problems concerning the development and distribution of medicines globally. It would incentivize the research and development of new pharmaceutical products that make substantial reductions in the global burden of disease. The Health Impact Fund is the creation of a team of researchers led by the Yale philosopher Thomas Pogge and the University of Calgary economist Aidan Hollis, and is promoted by the non-profit organization Incentives for Global Health (IGH).
A biological patent is a patent on an invention in the field of biology that by law allows the patent holder to exclude others from making, using, selling, or importing the protected invention for a limited period of time. The scope and reach of biological patents vary among jurisdictions, and may include biological technology and products, genetically modified organisms and genetic material. The applicability of patents to substances and processes wholly or partially natural in origin is a subject of debate.
The Medicines Patent Pool (MPP) is a Unitaid-backed international organisation founded in July 2010, based in Geneva, Switzerland. Its public health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted HIV treatments through voluntary licensing and patent pooling. Its goal is to improve access to affordable and appropriate HIV, hepatitis C and tuberculosis medicines in low- and middle-income countries (LMIC). In May 2020, the MPP become an implementing partner of the WHO's Covid-19 Technology Access Pool (C-TAP).
UAEM Maastricht chapter is the first chapter in The Netherlands that succeeded in making an agreement with the university signing the Socially Responsible Research and Licensing (SRRL) policy. "Access to Medicine" is the aim of the organization with focus on the Research and Development system and shared decision making with Maastricht University to actively pursue the goals drafted in Socially Responsible Research and Licensing (SRRL) policy. UAEM Maastricht has two active taskforces namely policy and awareness.
Access to medicines refers to the reasonable ability for people to get needed medicines required to achieve health. Such access is deemed to be part of the right to health as supported by international law since 1946.
Sustainable Development Goal 3, regarding "Good Health and Well-being", is one of the 17 Sustainable Development Goals established by the United Nations in 2015. The official wording is: "To ensure healthy lives and promote well-being for all at all ages." The targets of SDG 3 focus on various aspects of healthy life and healthy lifestyle. Progress towards the targets is measured using twenty-one indicators.
As of 4 December 2023, 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million vaccines were then being administered daily, only 22.3 percent of people in low-income countries had received at least a first vaccine by September 2022, according to official reports from national health agencies, which are collated by Our World in Data.
The TRIPS Agreement waiver is a joint intervention communication by South Africa and India to the TRIPS council of the World Trade Organization (WTO) on 2 October 2020.
Vaccine equity means ensuring that everyone in the world has equal access to vaccines. The importance of vaccine equity has been emphasized by researchers and public health experts during the COVID-19 pandemic but is relevant to other illnesses and vaccines as well. Historically, world-wide immunization campaigns have led to the eradication of smallpox and significantly reduced polio, measles, tuberculosis, diphtheria, whooping cough, and tetanus.
Priti Krishtel is a lawyer and advocate for health justice and increased public participation in the patent system. She co-founded the United States-based nonprofit organization the Initiative for Medicines, Access, and Knowledge.
The Initiative for Medicines, Access, and Knowledge, known as I-MAK, is a U.S.-based global 501(c)(3) organization that advocates in the public interest for affordable access to medicines, and a medicines system that is more inclusive of patients and the public.
Tahir Amin is a British lawyer for intellectual property and advocate for medicines access. He is a co-founder of the United States-based non-profit organization the Initiative for Medicines, Access and Knowledge (I-MAK).